Effectiveness and Safety of Tofacitinib for Ulcerative Colitis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Effectiveness and Safety of Tofacitinib for Ulcerative Colitis

Published:2021-09-09 Issue: Volume:Publish Ahead of Print Page:
ISSN:0192-0790
Container-title:Journal of Clinical Gastroenterology
language:en
Short-container-title:

Author:

Taneja Vikas,El-Dallal Mohammed,Haq Zadid,Tripathi Kartikeya,Systrom Hannah K.,Wang Linda F.,Said Hyder,Bain Paul A.,Zhou Youlian,Feuerstein Joseph D.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Gastroenterology

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Risk of nonmelanoma skin cancer in patients taking Janus kinase inhibitors for inflammatory bowel disease: A systematic review and meta-analysis;Dermatologica Sinica;2024-09-04

2. Tofacitinib use in ulcerative colitis: An expert consensus for day-to-day clinical practice;Indian Journal of Gastroenterology;2024-02

3. Safety and effectiveness of tofacitinib in ulcerative colitis: Data from TOFA-UC, a SN-IBD study;Digestive and Liver Disease;2024-01

4. Drug Survival and Long-term Outcome of Tofacitinib in Patients with Alopecia Areata: A Retrospective Study;Acta Dermato-Venereologica;2023-11-13

5. Bioactive glass in the treatment of ulcerative colitis to regulate the TLR4 / MyD88 / NF-κB pathway;Biomaterials Advances;2023-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP